Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Innoviva, Inc. (INVA) Anymore

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in October, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about Innoviva, Inc. (NASDAQ:INVA) in this article.

Is Innoviva, Inc. (NASDAQ:INVA) a worthy investment now? Money managers are taking a pessimistic view. The number of long hedge fund bets shrunk by 2 in recent months. Our calculations also showed that INVA isn’t among the 30 most popular stocks among hedge funds. INVA was in 22 hedge funds’ portfolios at the end of September. There were 24 hedge funds in our database with INVA positions at the end of the previous quarter.

Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 18 percentage points since May 2014 through December 3, 2018 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 24% through December 3, 2018. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Alex Denner Sarissa Capital

Let’s go over the recent hedge fund action regarding Innoviva, Inc. (NASDAQ:INVA).

What have hedge funds been doing with Innoviva, Inc. (NASDAQ:INVA)?

At the end of the third quarter, a total of 22 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -8% from one quarter earlier. Below, you can check out the change in hedge fund sentiment towards INVA over the last 13 quarters. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were increasing their holdings considerably (or already accumulated large positions).

INVA_dec2018

The largest stake in Innoviva, Inc. (NASDAQ:INVA) was held by Renaissance Technologies, which reported holding $71.7 million worth of stock at the end of September. It was followed by Sarissa Capital Management with a $69.1 million position. Other investors bullish on the company included GLG Partners, Consonance Capital Management, and D E Shaw.

Because Innoviva, Inc. (NASDAQ:INVA) has experienced falling interest from hedge fund managers, it’s easy to see that there lies a certain “tier” of hedge funds who were dropping their entire stakes last quarter. At the top of the heap, Peter Muller’s PDT Partners dropped the biggest position of the 700 funds watched by Insider Monkey, worth an estimated $4.2 million in stock. David Costen Haley’s fund, HBK Investments, also said goodbye to its stock, about $2.9 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest was cut by 2 funds last quarter.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Innoviva, Inc. (NASDAQ:INVA) but similarly valued. These stocks are Mazor Robotics Ltd. (NASDAQ:MZOR), Badger Meter, Inc. (NYSE:BMI), Criteo SA (NASDAQ:CRTO), and Rush Enterprises, Inc. (NASDAQ:RUSHA). This group of stocks’ market values are similar to INVA’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
MZOR 8 10500 2
BMI 9 107161 3
CRTO 11 176343 3
RUSHA 20 150213 1
Average 12 111054 2.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 12 hedge funds with bullish positions and the average amount invested in these stocks was $111 million. That figure was $220 million in INVA’s case. Rush Enterprises, Inc. (NASDAQ:RUSHA) is the most popular stock in this table. On the other hand Mazor Robotics Ltd. (NASDAQ:MZOR) is the least popular one with only 8 bullish hedge fund positions. Compared to these stocks Innoviva, Inc. (NASDAQ:INVA) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...